Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru

Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru

Tipo de Publicación: Artículo Científico

Año de Publicación : 2016

Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial.

López P, Lanata CF, Zambrano B, Cortés M, Andrade T, Amemiya I, Terrones C, Gil AI, Verastegui H, Marquez V, Crevat D, Jezorwski J, Noriega F.

Pediatr Infect Dis J. 2016 Oct;35(10):1140-7. doi: 10.1097/INF.0000000000001250.

https://www.ncbi.nlm.nih.gov/pubmed

https://scholar.google.es/​​​​​​​

https://www.scopus.com/​​​​​​​

Claudio F. Lanata de las Casas